Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2013, Article ID 254874, 17 pages
http://dx.doi.org/10.1155/2013/254874
Review Article

Altered Immune Regulation in Type 1 Diabetes

1Second Department of Medicine, Semmelweis University, Szentkirályi Street 46, Budapest 1088, Hungary
2First Department of Obstetrics and Gynecology, Semmelweis University, Baross Street 27, Budapest 1085, Hungary

Received 16 April 2013; Revised 19 June 2013; Accepted 4 July 2013

Academic Editor: Shervin Assassi

Copyright © 2013 András Zóka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. J. Taborsky Jr., B. Ahrén, and P. J. Havel, “Autonomic mediation of glucagon secretion during hypoglycemia: implications for impaired α-cell responses in type 1 diabetes,” Diabetes, vol. 47, no. 7, pp. 995–1005, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Blandino-Rosano, G. Perez-Arana, J. M. Mellado-Gil, C. Segundo, and M. Aguilar-Diosdado, “Anti-proliferative effect of pro-inflammatory cytokines in cultured β cells is associated with extracellular signal-regulated kinase 1/2 pathway inhibition: protective role of glucagon-like peptide-1,” Journal of Molecular Endocrinology, vol. 41, no. 1-2, pp. 35–44, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. E. E. Hamilton-Williams, S. E. Palmer, B. Charlton, and R. M. Slattery, “Beta cell MHC class I is a late requirement for diabetes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 11, pp. 6688–6693, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. X. Wang, A. Zhang, Y. Liu et al., “Anti-idiotypic antibody specific to GAD65 autoantibody prevents type 1 diabetes in the NOD mouse,” PLoS ONE, vol. 7, no. 2, article e32515, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Hauben, M. G. Roncarolo, U. Nevo, and M. Schwartz, “Beneficial autoimmunity in type 1 diabetes mellitus,” Trends in Immunology, vol. 26, no. 5, pp. 248–253, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. K. A. Metcalfe, G. A. Hitman, R. E. Rowe et al., “Concordance for type 1 diabetes in identical twins is affected by insulin genotype,” Diabetes Care, vol. 24, no. 5, pp. 838–842, 2001. View at Google Scholar · View at Scopus
  7. M. J. Redondo, J. Jeffrey, P. R. Fain, G. S. Eisenbarth, and T. Orban, “Concordance for islet autoimmunity among monozygotic twins,” The New England Journal of Medicine, vol. 359, no. 26, pp. 2849–2850, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Orešič, S. Simell, M. Sysi-Aho et al., “Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes,” The Journal of Experimental Medicine, vol. 205, no. 13, pp. 2975–2984, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. I. André, A. Gonzalez, B. Wang, J. Katz, C. Benoist, and D. Mathis, “Checkpoints in the progression of autoimmune disease: lessons from diabetes models,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 6, pp. 2260–2263, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. J. A. Todd, N. M. Walker, J. D. Cooper et al., “Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes,” Nature Genetics, vol. 39, no. 7, pp. 857–864, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. J. M. M. Howson, N. M. Walker, D. Clayton, and J. A. Todd, “Confirmation of HLA class II independent type 1 diabetes associations in the major histocompatibility complex including HLA-B and HLA-A,” Diabetes, Obesity and Metabolism, vol. 11, supplement 1, pp. 31–45, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Huang, D. Ellinghaus, A. Franke, B. Howie, and Y. Li, “1000 genomes-based imputation identifies novel and refined associations for the wellcome trust case control consortium phase 1 data,” European Journal of Human Genetics, vol. 20, no. 7, pp. 801–805, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. J. C. Barrett, D. G. Clayton, P. Concannon et al., “Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes,” Nature Genetics, vol. 41, no. 6, pp. 703–707, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. J. D. Cooper, D. J. Smyth, A. M. Smiles et al., “Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci,” Nature Genetics, vol. 40, no. 12, pp. 1399–1401, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. P. R. Burton, D. G. Clayton, L. R. Cardon et al., “Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls,” Nature, vol. 447, no. 7145, pp. 661–678, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Hakonarson, S. F. A. Grant, J. P. Bradfield et al., “A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene,” Nature, vol. 448, no. 7153, pp. 591–594, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. J. P. Bradfield, H.-Q. Qu, K. Wang et al., “A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci,” PLoS Genetics, vol. 7, no. 9, article e1002293, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Wallace, D. J. Smyth, M. Maisuria-Armer, N. M. Walker, J. A. Todd, and D. G. Clayton, “The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes,” Nature Genetics, vol. 42, no. 1, pp. 68–71, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. S. F. A. Grant, H.-Q. Qu, J. P. Bradfield et al., “Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetes,” Diabetes, vol. 58, no. 1, pp. 290–295, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Hakonarson, H.-Q. Qu, J. P. Bradfield et al., “A novel susceptibility locus for type 1 diabetes on chr12q13 identified by a genome-wide association study,” Diabetes, vol. 57, no. 4, pp. 1143–1146, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. E. T. Luning Prak, M. Monestier, and R. A. Eisenberg, “B cell receptor editing in tolerance and autoimmunity,” Annals of the New York Academy of Sciences, vol. 1217, no. 1, pp. 96–121, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. M. A. McGargill, J. M. Derbinski, and K. A. Hogquist, “Receptor editing in developing T cells,” Nature Immunology, vol. 1, no. 4, pp. 336–341, 2000. View at Google Scholar · View at Scopus
  23. C. C. Goodnow, J. Sprent, B. F. de St. Groth, and C. G. Vinuesa, “Cellular and genetic mechanisms of self tolerance and autoimmunity,” Nature, vol. 435, no. 7042, pp. 590–597, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Boettler and M. von Herrath, “Protection against or triggering of type 1 diabetes? Different roles for viral infections,” Expert Review of Clinical Immunology, vol. 7, no. 1, pp. 45–53, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Vafiadis, S. T. Bennett, J. A. Todd et al., “Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus,” Nature Genetics, vol. 15, no. 3, pp. 289–292, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Fan, W. A. Rudert, M. Grupillo, J. He, G. Sisino, and M. Trucco, “Thymus-specific deletion of insulin induces autoimmune diabetes,” The EMBO Journal, vol. 28, no. 18, pp. 2812–2824, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Klein and K. Jovanovic, “Regulatory T cell differentiation: turning harmful into useful,” Immunity, vol. 37, no. 3, pp. 441–443, 2012. View at Google Scholar
  28. M. A. Curotto de Lafaille and J. J. Lafaille, “Natural and adaptive Foxp3+ regulatory T cells: more of the same or a division of labor?” Immunity, vol. 30, no. 5, pp. 626–635, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. V. Plagnol, J. M. M. Howson, D. J. Smyth et al., “Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases,” PLoS Genetics, vol. 7, no. 8, article e1002216, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. “T1DBase—home page,” June 2013, http://www.t1dbase.org/page/Welcome/display.
  31. J. Nolting, C. Daniel, S. Reuter et al., “Retinoic acid can enhance conversion of naive into regulatory T cells independently of secreted cytokines,” The Journal of Experimental Medicine, vol. 206, no. 10, pp. 2131–2139, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. M. J. Benson, K. Pino-Lagos, M. Rosemblatt, and R. J. Noelle, “All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation,” The Journal of Experimental Medicine, vol. 204, no. 8, pp. 1765–1774, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. T. L. Denning, Y.-C. Wang, S. R. Patel, I. R. Williams, and B. Pulendran, “Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses,” Nature Immunology, vol. 8, no. 10, pp. 1086–1094, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Z. Josefowicz, L.-F. Lu, and A. Y. Rudensky, “Regulatory T cells: mechanisms of differentiation and function,” Annual Review of Immunology, vol. 30, pp. 531–564, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. F. Lühder, P. Höglund, J. P. Allison, C. Benoist, and D. Mathis, “Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes,” The Journal of Experimental Medicine, vol. 187, no. 3, pp. 427–432, 1998. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Khattri, J. A. Auger, M. D. Griffin, A. H. Sharpe, and J. A. Bluestone, “Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses,” The Journal of Immunology, vol. 162, no. 10, pp. 5784–5791, 1999. View at Google Scholar · View at Scopus
  37. W. Łuczyński, N. Wawrusiewicz-Kurylonek, A. Stasiak-Barmuta et al., “Diminished expression of ICOS, GITR and CTLA-4 at the mRNA level in T regulatory cells of children with newly diagnosed type 1 diabetes,” Acta Biochimica Polonica, vol. 56, no. 2, pp. 361–370, 2009. View at Google Scholar · View at Scopus
  38. M. Araki, D. Chung, S. Liu et al., “Genetic evidence that the differential expression of the ligand-independent isoform of CTLA-4 is the molecular basis of the Idd5.1 type 1 diabetes region in nonobese diabetic mice,” The Journal of Immunology, vol. 183, no. 8, pp. 5146–5157, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. S.-J. Shieh, F.-C. Chou, P.-N. Yu et al., “Transgenic expression of single-chain anti-CTLA-4 Fv on β cells protects nonobese diabetic mice from autoimmune diabetes,” The Journal of Immunology, vol. 183, no. 4, pp. 2277–2285, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Lundholm, V. Motta, A. Löfgren-Burström et al., “Defective induction of CTLA-4 in the NOD mouse is controlled by the NOD allele of Idd3/IL-2 and a novel locus (Ctex) telomeric on chromosome 1,” Diabetes, vol. 55, no. 2, pp. 538–544, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. “Dose-effect relationship of low-dose IL-2 in type 1 diabetes,” http://clinicaltrials.gov/ct2/show/NCT01353833.
  42. “Home—gene—ncbi,” June 2013, http://www.ncbi.nlm.nih.gov/gene/.
  43. S. Martin, D. Wolf-Eichbaum, G. Duinkerken et al., “Development of type 1 diabetes despite severe hereditary B-cell deficiency,” The New England Journal of Medicine, vol. 345, no. 14, pp. 1036–1040, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Xiu, C. P. Wong, J.-D. Bouaziz et al., “B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in FcγR effector functions,” The Journal of Immunology, vol. 180, no. 5, pp. 2863–2875, 2008. View at Google Scholar · View at Scopus
  45. S. H. Smith and T. F. Tedder, “Targeting B-cells mitigates autoimmune diabetes in NOD mice: what is plan b?” Diabetes, vol. 58, no. 7, pp. 1479–1481, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Thien, T. G. Phan, S. Gardam et al., “Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches,” Immunity, vol. 20, no. 6, pp. 785–798, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Yanaba, A. Yoshizaki, Y. Asano, T. Kadono, T. F. Tedder, and S. Sato, “IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model,” The American Journal of Pathology, vol. 178, no. 2, pp. 735–743, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. X. Chen and P. E. Jensen, “Cutting edge: primary B lymphocytes preferentially expand allogeneic FoxP3+ CD4 T cells,” The Journal of Immunology, vol. 179, no. 4, pp. 2046–2050, 2007. View at Google Scholar · View at Scopus
  49. N. K. Jerne, “Towards a network theory of the immune system,” Annales d'Immunologie, vol. 125C, no. 1-2, pp. 373–389, 1974. View at Google Scholar · View at Scopus
  50. C. S. Hampe, “Protective role of anti-idiotypic antibodies in autoimmunity—lessons for type 1 diabetes,” Autoimmunity, vol. 45, no. 4, pp. 320–331, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. J. C. Brown and L. S. Rodkey, “Autoregulation of an antibody response via network-induced auto-anti-idiotype,” The Journal of Experimental Medicine, vol. 150, no. 1, pp. 67–85, 1979. View at Google Scholar · View at Scopus
  52. L. Scaglia, C. J. Cahill, D. T. Finegood, and S. Bonner-Weir, “Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat,” Endocrinology, vol. 138, no. 4, pp. 1736–1741, 1997. View at Publisher · View at Google Scholar · View at Scopus
  53. J. D. Trudeau, J. P. Dutz, E. Arany, D. J. Hill, W. E. Fieldus, and D. T. Finegood, “Neonatal β-cell apoptosis: a trigger for autoimmune diabetes?” Diabetes, vol. 49, no. 1, pp. 1–7, 2000. View at Google Scholar · View at Scopus
  54. S. A. Kassem, I. Ariel, P. S. Thornton, I. Scheimberg, and B. Glaser, “β-Cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy,” Diabetes, vol. 49, no. 8, pp. 1325–1333, 2000. View at Google Scholar · View at Scopus
  55. P. Höglund, J. Mintern, C. Waltzinger, W. Heath, C. Benoist, and D. Mathis, “Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes,” The Journal of Experimental Medicine, vol. 189, no. 2, pp. 331–339, 1999. View at Publisher · View at Google Scholar · View at Scopus
  56. B. A. O'Brien, Y. Huang, X. Geng, J. P. Dutz, and D. T. Finegood, “Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced,” Diabetes, vol. 51, no. 8, pp. 2481–2488, 2002. View at Google Scholar · View at Scopus
  57. H. S. Kim, M. S. Han, K. W. Chung et al., “Toll-like receptor 2 senses β-cell death and contributes to the initiation of autoimmune diabetes,” Immunity, vol. 27, no. 2, pp. 321–333, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. H.-S. Jun, C.-S. Yoon, L. Zbytnuik, N. van Rooijen, and J.-W. Yoon, “The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice,” The Journal of Experimental Medicine, vol. 189, no. 2, pp. 347–358, 1999. View at Publisher · View at Google Scholar · View at Scopus
  59. E. M. Carrington, C. Kos, Y. Zhan, B. Krishnamurthy, and J. Allison, “Reducing or increasing β-cell apoptosis without inflammation does not affect diabetes initiation in neonatal NOD mice,” European Journal of Immunology, vol. 41, no. 8, pp. 2238–2247, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. J. C. Byrne, J. Ní Gabhann, E. Lazzari et al., “Genetics of SLE: functional relevance for monocytes/macrophages in disease,” Clinical and Developmental Immunology, vol. 2012, Article ID 582352, 15 pages, 2012. View at Publisher · View at Google Scholar
  61. A. Sabioncello, S. Rabatic, and M. Kadrnka-Lovrencic, “Decreased phagocytosis and antibody-dependent cellular cytotoxicity (ADCC) in type-1 diabetes,” Biomedicine, vol. 35, no. 7-8, pp. 227–229, 1981. View at Google Scholar · View at Scopus
  62. A. Espinoza-Jiménez, A. N. Peón, and L. I. Terrazas, “Alternatively activated macrophages in types 1 and 2 diabetes,” Mediators of Inflammation, vol. 2012, 10 pages, 2012. View at Publisher · View at Google Scholar
  63. M.-S. Lee, H.-J. Kwon, and H. S. Kim, “Macrophages from nonobese diabetic mouse have a selective defect in IFN-γ but not IFN-α/β receptor pathway,” Journal of Clinical Immunology, vol. 23, no. 4, pp. 753–761, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. D. K. Dalton, S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart, “Multiple defects of immune cell function in mice with disrupted interferon-γ genes,” Science, vol. 259, no. 5102, pp. 1739–1742, 1993. View at Google Scholar · View at Scopus
  65. S. Turley, L. Poirot, M. Hattori, C. Benoist, and D. Mathis, “Physiological β cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model,” The Journal of Experimental Medicine, vol. 198, no. 10, pp. 1527–1537, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. N. A. Danke, D. M. Koelle, C. Yee, S. Beheray, and W. W. Kwok, “Autoreactive T cells in healthy individuals,” The Journal of Immunology, vol. 172, no. 10, pp. 5967–5972, 2004. View at Google Scholar · View at Scopus
  67. T. Orban, K. Farkas, H. Jalahej et al., “Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy,” The Journal of Autoimmunity, vol. 34, no. 4, pp. 408–415, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. S. Hugues, E. Mougneau, W. Ferlin et al., “Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic β cells,” Immunity, vol. 16, no. 2, pp. 169–181, 2002. View at Publisher · View at Google Scholar · View at Scopus
  69. G. R. Rayat, R. V. Rajotte, J. G. Lyon, J. M. Dufour, B. V. Hacquoil, and G. S. Korbutt, “Immunization with streptozotocin-treated NOD mouse islets inhibits the onset of autoimmune diabetes in NOD mice,” The Journal of Autoimmunity, vol. 21, no. 1, pp. 11–15, 2003. View at Publisher · View at Google Scholar · View at Scopus
  70. A. Gonzalez, I. Andre-Schmutz, C. Carnaud, D. Mathis, and C. Benoist, “Damage control, rather than unresponsiveness, effected by protective DX5+ T cells in autoimmune diabetes,” Nature Immunology, vol. 2, no. 12, pp. 1117–1125, 2001. View at Publisher · View at Google Scholar · View at Scopus
  71. M.-S. Lee, R. Mueller, L. S. Wicker, L. B. Peterson, and N. Sarvetnick, “IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity,” The Journal of Experimental Medicine, vol. 183, no. 6, pp. 2663–2668, 1996. View at Publisher · View at Google Scholar · View at Scopus
  72. T. W. Mak and M. Saunders, The Immune Response: Basic and Clinical Principles, Academic Press, 2005.
  73. K. L. Rock, A. Hearn, C.-J. Chen, and Y. Shi, “Natural endogenous adjuvants,” Springer Seminars in Immunopathology, vol. 26, no. 3, pp. 231–246, 2005. View at Publisher · View at Google Scholar · View at Scopus
  74. D. W. Dresser, “Specific inhibition of antibody production. II. Paralysis induced in adult mice by small quantities of protein antigen,” Immunology, vol. 5, no. 3, pp. 378–388, 1962. View at Google Scholar · View at Scopus
  75. H. N. Claman, “Tolerance to a protein antigen in adult mice and the effect of nonspecific factors,” The Journal of Immunology, vol. 91, pp. 833–839, 1963. View at Google Scholar · View at Scopus
  76. P. Bretscher and M. Cohn, “A theory of self-nonself discrimination,” Science, vol. 169, no. 3950, pp. 1042–1049, 1970. View at Google Scholar · View at Scopus
  77. D. L. Rosenstreich and S. B. Mizel, “Signal requirements for T lymphocyte activation. I. Replacement of macrophage function with phorbol myristic acetate,” The Journal of Immunology, vol. 123, no. 4, pp. 1749–1754, 1979. View at Google Scholar · View at Scopus
  78. H. Quill and R. H. Schwartz, “Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferative nonresponsiveness,” The Journal of Immunology, vol. 138, no. 11, pp. 3704–3712, 1987. View at Google Scholar · View at Scopus
  79. H. Kono and K. L. Rock, “How dying cells alert the immune system to danger,” Nature Reviews Immunology, vol. 8, no. 4, pp. 279–289, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. R. W. Finberg, J. P. Wang, and E. A. Kurt-Jones, “Toll like receptors and viruses,” Reviews in Medical Virology, vol. 17, no. 1, pp. 35–43, 2007. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Hallman, M. Rämet, and R. A. Ezekowitz, “Toll-like receptors as sensors of pathogens,” Pediatric Research, vol. 50, no. 3, pp. 315–321, 2001. View at Google Scholar · View at Scopus
  82. Y. Shi, W. Zheng, and K. L. Rock, “Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 26, pp. 14590–14595, 2000. View at Publisher · View at Google Scholar · View at Scopus
  83. M. Bellone, G. Iezzi, P. Rovere et al., “Processing of engulfed apoptotic bodies yields T cell epitopes,” The Journal of Immunology, vol. 159, no. 11, pp. 5391–5399, 1997. View at Google Scholar · View at Scopus
  84. M. L. Albert, B. Sauter, and N. Bhardwaj, “Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLS,” Nature, vol. 392, no. 6671, pp. 86–89, 1998. View at Publisher · View at Google Scholar · View at Scopus
  85. K. Inaba, S. Turley, F. Yamaide et al., “Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells,” The Journal of Experimental Medicine, vol. 188, no. 11, pp. 2163–2173, 1998. View at Publisher · View at Google Scholar · View at Scopus
  86. L. Horváth, L. Cervenak, M. Oroszlán et al., “Antibodies against different epitopes of heat-shock protein 60 in children with type 1 diabetes mellitus,” Immunology Letters, vol. 80, no. 3, pp. 155–162, 2002. View at Publisher · View at Google Scholar · View at Scopus
  87. S. Takizawa, T. Endo, X. Wanjia, S. Tanaka, M. Takahashi, and T. Kobayashi, “HSP 10 is a new autoantigen in both autoimmune pancreatitis and fulminant type 1 diabetes,” Biochemical and Biophysical Research Communications, vol. 386, no. 1, pp. 192–196, 2009. View at Publisher · View at Google Scholar · View at Scopus
  88. A. Shimada, T. Kasatani, I. Takei et al., “Immune response to heat-shock protein correlates with induction of insulitis in I-Eαd transgenic NOD mice,” Diabetes, vol. 45, no. 2, pp. 165–169, 1996. View at Google Scholar · View at Scopus
  89. P. K. Srivastava and R. G. Maki, “Stress-induced proteins in immune response to cancer,” Current Topics in Microbiology and Immunology, vol. 167, pp. 109–123, 1991. View at Google Scholar · View at Scopus
  90. H. Singh-Jasuja, H. U. Scherer, N. Hilf et al., “The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor,” European Journal of Immunology, vol. 30, no. 8, pp. 2211–2215, 2000. View at Google Scholar
  91. M. C. Kuppner, R. Gastpar, S. Gelwer et al., “The role of heat shock protein (hsp70) in dendritic cell maturation: hsp70 induces the maturation of immature dendritic cells but reduces DC differentiation from monocyte precursors,” European Journal of Immunology, vol. 31, no. 5, pp. 1602–1609, 2001. View at Google Scholar
  92. A. Asea, S.-K. Kraeft, E. A. Kurt-Jones et al., “HSP70 stimulates cytokine production through a CD 14-dependant pathway, demonstrating its dual role as a chaperone and cytokine,” Nature Medicine, vol. 6, no. 4, pp. 435–442, 2000. View at Publisher · View at Google Scholar · View at Scopus
  93. B. Gao and M.-F. Tsan, “Recombinant human heat shock protein 60 does not induce the release of tumor necrosis factor α from murine macrophages,” The Journal of Biological Chemistry, vol. 278, no. 25, pp. 22523–22529, 2003. View at Publisher · View at Google Scholar · View at Scopus
  94. E. Schmitt, M. Gehrmann, M. Brunet, G. Multhoff, and C. Garrido, “Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy,” Journal of Leukocyte Biology, vol. 81, no. 1, pp. 15–27, 2007. View at Publisher · View at Google Scholar · View at Scopus
  95. S. Pawaria and R. J. Binder, “CD91-dependent programming of T-helper cell responses following heat shock protein immunization,” Nature Communications, vol. 2, no. 1, article 521, 2011. View at Publisher · View at Google Scholar · View at Scopus
  96. J.-I. Miyagawa, M. Miuchi, and M. Namba, “Incretin-based therapy in patients with type 1 diabetes mellitus,” Nippon Rinsho, vol. 69, no. 5, pp. 923–929, 2011. View at Google Scholar · View at Scopus
  97. Y. Shi, “Caught red-handed: uric acid is an agent of inflammation,” The Journal of Clinical Investigation, vol. 120, no. 6, pp. 1809–1811, 2010. View at Publisher · View at Google Scholar · View at Scopus
  98. M. Knip, S. M. Virtanen, and H. K. Åkerblom, “Infant feeding and the risk of type 1 diabetes,” The American Journal of Clinical Nutrition, vol. 91, no. 5, pp. 1506S–1513S, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. K. T. Coppieters, T. Boettler, and M. von Herrath, “Virus infections in type 1 diabetes,” Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 1, article a007682, 2012. View at Publisher · View at Google Scholar
  100. D. R. Gamble, M. L. Kinsley, M. G. FitzGerald, R. Bolton, and K. W. Taylor, “Viral antibodies in diabetes mellitus,” British Medical Journal, vol. 3, no. 5671, pp. 627–630, 1969. View at Google Scholar · View at Scopus
  101. G. B. Clements, D. N. Galbraith, and K. W. Taylor, “Coxsackie B virus infection and onset of childhood diabetes,” Lancet, vol. 346, no. 8969, pp. 221–223, 1995. View at Google Scholar · View at Scopus
  102. A. Shimada and T. Maruyama, “Encephalomyocarditis-virus-induced diabetes model resembles ‘fulminant’ type 1 diabetes in humans,” Diabetologia, vol. 47, no. 10, pp. 1854–1855, 2004. View at Publisher · View at Google Scholar · View at Scopus
  103. N. C. Schloot, S. J. M. Willemen, G. Duinkerken, J. W. Drijfhout, R. R. P. de Vries, and B. O. Roep, “Molecular mimicry in type 1 diabetes mellitus revisited: T-cell clones to GAD65 peptides with sequence homology to coxsackie or proinsulin peptides do not crossreact with homologous counterpart,” Human Immunology, vol. 62, no. 4, pp. 299–309, 2001. View at Publisher · View at Google Scholar · View at Scopus
  104. N. Sevilla, D. Homann, M. von Herrath et al., “Virus-induced diabetes in a transgenic model: role of cross-reacting viruses and quantitation of effector T cells needed to cause disease,” Journal of Virology, vol. 74, no. 7, pp. 3284–3292, 2000. View at Publisher · View at Google Scholar · View at Scopus
  105. U. Christen, K. H. Edelmann, D. B. McGavern et al., “A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes,” The Journal of Clinical Investigation, vol. 114, no. 9, pp. 1290–1298, 2004. View at Publisher · View at Google Scholar · View at Scopus
  106. S. Tracy, K. M. Drescher, N. M. Chapman et al., “Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence,” Journal of Virology, vol. 76, no. 23, pp. 12097–12111, 2002. View at Publisher · View at Google Scholar · View at Scopus
  107. J. A. Pane, N. L. Webster, K. L. Graham, G. Holloway, C. Zufferey, and B. S. Coulson, “Rotavirus acceleration of murine type 1 diabetes is associated with a T helper 1-dependent specific serum antibody response and virus effects in regional lymph nodes,” Diabetologia, vol. 56, no. 3, pp. 573–582, 2013. View at Google Scholar
  108. O. Vaarala, M. Knip, J. Paronen et al., “Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes,” Diabetes, vol. 48, no. 7, pp. 1389–1394, 1999. View at Publisher · View at Google Scholar · View at Scopus
  109. D. L. Eizirik, M. L. Colli, and F. Ortis, “The role of inflammation in insulitis and Β-cell loss in type 1 diabetes,” Nature Reviews Endocrinology, vol. 5, no. 4, pp. 219–226, 2009. View at Publisher · View at Google Scholar · View at Scopus
  110. I. Santin, F. Moore, M. L. Colli et al., “PTPN2, a candidate gene for type 1 diabetes, modulates pancreatic β-cell apoptosis via regulation of the BH3-only protein bim,” Diabetes, vol. 60, no. 12, pp. 3279–3288, 2011. View at Publisher · View at Google Scholar · View at Scopus
  111. U. Walter, T. Toepfer, K. E. J. Dittmar et al., “Pancreatic NOD beta cells express MHC class II protein and the frequency of I-Ag7 mRNA-expressing beta cells strongly increases during progression to autoimmune diabetes,” Diabetologia, vol. 46, no. 8, pp. 1106–1114, 2003. View at Publisher · View at Google Scholar · View at Scopus
  112. E. N. Gurzov and D. L. Eizirik, “Bcl-2 proteins in diabetes: mitochondrial pathways of β-cell death and dysfunction,” Trends in Cell Biology, vol. 21, no. 7, pp. 424–431, 2011. View at Publisher · View at Google Scholar · View at Scopus
  113. D. A. Cunha, M. Igoillo-Esteve, E. N. Gurzov et al., “Death protein 5 and p53-upregulated modulator of apoptosis mediate the endoplasmic reticulum stress-mitochondrial dialog triggering lipotoxic rodent and human β-cell apoptosis,” Diabetes, vol. 61, no. 11, pp. 2763–2775, 2012. View at Publisher · View at Google Scholar
  114. E. N. Gurzov, C. M. Germano, D. A. Cunha et al., “p53 up-regulated modulator of apoptosis (PUMA) activation contributes to pancreatic β-cell apoptosis induced by proinflammatory cytokines and endoplasmic reticulum stress,” The Journal of Biological Chemistry, vol. 285, no. 26, pp. 19910–19920, 2010. View at Publisher · View at Google Scholar · View at Scopus
  115. J. Barthson, C. M. Germano, F. Moore et al., “Cytokines tumor necrosis factor-α and interferon-γ induce pancreatic β-cell apoptosis through STAT1-mediated bim protein activation,” The Journal of Biological Chemistry, vol. 286, no. 45, pp. 39632–39643, 2011. View at Publisher · View at Google Scholar · View at Scopus
  116. D. L. Eizirik, M. Sammeth, T. Bouckenooghe et al., “The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines,” PLoS Genetics, vol. 8, no. 3, article e1002552, 2012. View at Publisher · View at Google Scholar · View at Scopus
  117. Y. Yamada, Y. Okubo, A. Shimada et al., “Acceleration of diabetes development in CXC chemokine receptor 3 (CXCR3)-deficient NOD mice,” Diabetologia, vol. 55, no. 8, pp. 2238–2245, 2012. View at Publisher · View at Google Scholar · View at Scopus
  118. S. Frigerio, T. Junt, B. Lu et al., “β cells are responsible for CXCR3-mediated T-cell infiltration in insulitis,” Nature Medicine, vol. 8, no. 12, pp. 1414–1420, 2002. View at Publisher · View at Google Scholar · View at Scopus
  119. U. Christen, D. B. McGavern, A. D. Luster, M. G. von Herrath, and M. B. A. Oldstone, “Among CXCR3 chemokines, IFN-γ-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-γ (CXCL9) imprints a pattern for the subsequent development of autoimmune disease,” The Journal of Immunology, vol. 171, no. 12, pp. 6838–6845, 2003. View at Google Scholar · View at Scopus
  120. A. K. Steck, T. K. Armstrong, S. R. Babu, and G. S. Eisenbarth, “Stepwise or linear decrease in penetrance of type 1 diabetes with lower-risk HLA genotypes over the past 40 years,” Diabetes, vol. 60, no. 3, pp. 1045–1049, 2011. View at Publisher · View at Google Scholar · View at Scopus
  121. C. Jacovetti, A. Abderrahmani, G. Parnaud et al., “MicroRNAs contribute to compensatory β cell expansion during pregnancy and obesity,” The Journal of Clinical Investigation, vol. 122, no. 10, pp. 3541–3551, 2012. View at Publisher · View at Google Scholar
  122. Q. Lu, “The critical importance of epigenetics in autoimmunity,” The Journal of Autoimmunity, vol. 41, pp. 1–5, 2013. View at Publisher · View at Google Scholar
  123. A. Toker, D. Engelbert, G. Garg et al., “Active demethylation of the Foxp3 locus leads to the generation of stable regulatory T cells within the thymus,” The The Journal of Immunology, vol. 190, no. 7, pp. 3180–3188, 2013. View at Publisher · View at Google Scholar
  124. M. K. Shanmugam and G. Sethi, “Role of epigenetics in inflammation-associated diseases,” Subcellular Biochemistry, vol. 61, pp. 627–657, 2012. View at Google Scholar
  125. E. M. Akirav, J. Lebastchi, E. M. Galvan et al., “Detection of β cell death in diabetes using differentially methylated circulating DNA,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 47, pp. 19018–19023, 2011. View at Publisher · View at Google Scholar · View at Scopus
  126. F. Miao, D. D. Smith, L. Zhang, A. Min, W. Feng, and R. Natarajan, “Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation an epigenetic study in diabetes,” Diabetes, vol. 57, no. 12, pp. 3189–3198, 2008. View at Publisher · View at Google Scholar · View at Scopus
  127. F. Miao, Z. Chen, L. Zhang et al., “Profiles of epigenetic histone post-translational modifications at type 1 diabetes susceptible genes,” The Journal of Biological Chemistry, vol. 287, no. 20, pp. 16335–16345, 2012. View at Publisher · View at Google Scholar
  128. Z. Xu, G. M. Lefevre, and G. Felsenfeld, “Chromatin structure, epigenetic mechanisms and long-range interactions in the human insulin locus,” Diabetes, Obesity and Metabolism, vol. 14, supplement 3, pp. 1–11, 2012. View at Google Scholar
  129. R. Hezova, O. Slaby, P. Faltejskova et al., “microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients,” Cellular Immunology, vol. 260, no. 2, pp. 70–74, 2010. View at Publisher · View at Google Scholar · View at Scopus
  130. L.-F. Lu, M. P. Boldin, A. Chaudhry et al., “Function of miR-146a in controlling treg cell-mediated regulation of Th1 responses,” Cell, vol. 142, no. 6, pp. 914–929, 2010. View at Publisher · View at Google Scholar · View at Scopus
  131. M. Guttman, J. Donaghey, B. W. Carey et al., “LincRNAs act in the circuitry controlling pluripotency and differentiation,” Nature, vol. 477, no. 7364, pp. 295–300, 2011. View at Publisher · View at Google Scholar · View at Scopus
  132. U. A. Ørom and R. Shiekhattar, “Noncoding RNAs and enhancers: complications of a long-distance relationship,” Trends in Genetics, vol. 27, no. 10, pp. 433–439, 2011. View at Publisher · View at Google Scholar · View at Scopus
  133. U. A. Ørom, T. Derrien, M. Beringer et al., “Long noncoding RNAs with enhancer-like function in human cells,” Cell, vol. 143, no. 1, pp. 46–58, 2010. View at Publisher · View at Google Scholar · View at Scopus
  134. T. Pullen and G. Rutter, “An islet-specific long non-coding RNA (lncRNA) expressed from the Pdx1 locus regulates Pdx1 activity,” Diabetologia, vol. 55, p. 212, 2012. View at Google Scholar
  135. M. G. von Herrath, R. S. Fujinami, and J. L. Whitton, “Microorganisms and autoimmunity: making the barren field fertile?” Nature Reviews Microbiology, vol. 1, no. 2, pp. 151–157, 2003. View at Google Scholar · View at Scopus
  136. E. V. Moltchanova, N. Schreier, N. Lammi, and M. Karvonen, “Seasonal variation of diagnosis of type 1 diabetes mellitus in children worldwide,” Diabetic Medicine, vol. 26, no. 7, pp. 673–678, 2009. View at Publisher · View at Google Scholar · View at Scopus
  137. E. K. Gyurus, C. Patterson, G. Soltesz et al., “Twenty-one years of prospective incidence of childhood type 1 diabetes in Hungary—the rising trend continues (or peaks and highlands?),” Pediatric Diabetes, vol. 13, no. 1, pp. 21–25, 2012. View at Publisher · View at Google Scholar · View at Scopus
  138. G. Bruno and A. Landi, “Epidemiology and costs of diabetes,” Transplantation Proceedings, vol. 43, no. 1, pp. 327–329, 2011. View at Publisher · View at Google Scholar · View at Scopus
  139. M. Wills-Karp, J. Santeliz, and C. L. Karp, “The germless theory of allergic disease: revisiting the hygiene hypothesis,” Nature Reviews Immunology, vol. 1, no. 1, pp. 69–75, 2001. View at Google Scholar · View at Scopus
  140. D. Dabelea, C. Pihoker, J. W. Talton et al., “Etiological approach to characterization of diabetes type: the SEARCH for Diabetes in Youth Study,” Diabetes Care, vol. 34, no. 7, pp. 1628–1633, 2011. View at Google Scholar · View at Scopus
  141. X. Clemente-Casares, S. Tsai, C. Huang, and P. Santamaria, “Antigen-specific therapeutic approaches in type 1 diabetes,” Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 2, article a007773, 2012. View at Google Scholar
  142. X. Li, L. Liao, X. Yan et al., “Protective effects of 1-α-hydroxyvitamin D3 on residual β-cell function in patients with adult-onset latent autoimmune diabetes (LADA),” Diabetes/Metabolism Research and Reviews, vol. 25, no. 5, pp. 411–416, 2009. View at Publisher · View at Google Scholar · View at Scopus
  143. M. Walter, T. Kaupper, K. Adler, J. Foersch, E. Bonifacio, and A.-G. Ziegler, “No effect of the 1α,25-dihydroxyvitamin D3 on β-cell residual function and insulin requirement in adults with new-onset type 1 diabetes,” Diabetes Care, vol. 33, no. 7, pp. 1443–1448, 2010. View at Publisher · View at Google Scholar · View at Scopus
  144. K. L. Munger, L. I. Levin, J. Massa, R. Horst, T. Orban, and A. Ascherio, “Preclinical serum 25-hydroxyvitamin D levels and risk of type 1 diabetes in a cohort of US military personnel,” American Journal of Epidemiology, vol. 177, no. 5, pp. 411–419, 2013. View at Google Scholar
  145. T. Varga, A. Somogyi, G. Barna et al., “Higher serum DPP-4 enzyme activity and decreased lymphocyte CD26 expression in type 1 diabetes,” Pathology and Oncology Research, vol. 17, no. 4, pp. 925–930, 2011. View at Publisher · View at Google Scholar · View at Scopus
  146. I. Hadjiyanni, K. A. Siminovitch, J. S. Danska, and D. J. Drucker, “Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells,” Diabetologia, vol. 53, no. 4, pp. 730–740, 2010. View at Publisher · View at Google Scholar · View at Scopus
  147. S. L. Ellis, E. G. Moser, J. K. Snell-Bergeon, A. S. Rodionova, R. M. Hazenfield, and S. K. Garg, “Effect of sitagliptin on glucose control in adult patients with type1 diabetes: a pilot, double-blind, randomized, crossover trial,” Diabetic Medicine, vol. 28, no. 10, pp. 1176–1181, 2011. View at Publisher · View at Google Scholar · View at Scopus
  148. U. Kielgast, T. Krarup, J. J. Holst, and S. Madsbad, “Four weeks of treatment with liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual beta-cell function,” Diabetes care, vol. 34, no. 7, pp. 1463–1468, 2011. View at Google Scholar · View at Scopus
  149. R. G. Miller, A. M. Secrest, R. K. Sharma, T. J. Songer, and T. J. Orchard, “Improvements in the life expectancy of type 1 diabetes the Pittsburgh Epidemiology of Diabetes Complications Study Cohort,” Diabetes, vol. 61, no. 11, pp. 2987–2992, 2012. View at Google Scholar